A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 40,958 shares of MDGL stock, worth $8.89 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
40,958
Previous 40,958 -0.0%
Holding current value
$8.89 Million
Previous $11.5 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$193.33 - $291.99 $10.2 Million - $15.4 Million
-52,613 Reduced 56.23%
40,958 $11.5 Million
Q1 2024

May 15, 2024

BUY
$171.37 - $283.23 $16 Million - $26.5 Million
93,571 New
93,571 $25 Million
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $25.3 Million - $39 Million
172,900 New
172,900 $25.3 Million
Q1 2023

May 15, 2023

BUY
$231.06 - $307.08 $922,622 - $1.23 Million
3,993 New
3,993 $967,000
Q3 2022

Nov 14, 2022

BUY
$60.57 - $79.51 $1.39 Million - $1.82 Million
22,876 New
22,876 $1.49 Million
Q4 2021

Feb 14, 2022

SELL
$72.34 - $95.09 $2.18 Million - $2.86 Million
-30,100 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$78.35 - $105.02 $2.36 Million - $3.16 Million
30,100 New
30,100 $2.4 Million
Q2 2020

Aug 14, 2020

SELL
$60.13 - $125.71 $4.74 Million - $9.92 Million
-78,900 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$66.76 - $93.49 $5.27 Million - $7.38 Million
78,900 New
78,900 $5.27 Million
Q4 2019

Feb 14, 2020

SELL
$84.28 - $118.5 $2.57 Million - $3.62 Million
-30,521 Closed
0 $0
Q3 2019

Nov 15, 2019

SELL
$84.4 - $106.53 $2.31 Million - $2.92 Million
-27,379 Reduced 47.29%
30,521 $2.63 Million
Q2 2019

Aug 14, 2019

BUY
$91.13 - $142.5 $3.38 Million - $5.29 Million
37,133 Added 178.81%
57,900 $6.07 Million
Q1 2019

May 15, 2019

SELL
$103.48 - $143.84 $3.34 Million - $4.64 Million
-32,233 Reduced 60.82%
20,767 $2.6 Million
Q4 2018

Feb 14, 2019

SELL
$94.77 - $215.54 $3.96 Million - $9.01 Million
-41,800 Reduced 44.09%
53,000 $5.97 Million
Q3 2018

Nov 14, 2018

BUY
$207.3 - $300.31 $19.7 Million - $28.5 Million
94,800 New
94,800 $20.3 Million
Q2 2018

Aug 14, 2018

SELL
$101.55 - $313.9 $4.05 Million - $12.5 Million
-39,900 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$93.35 - $149.04 $7.48 Million - $11.9 Million
-80,100 Reduced 66.75%
39,900 $4.66 Million
Q4 2017

Feb 14, 2018

BUY
$39.35 - $97.37 $4.72 Million - $11.7 Million
120,000
120,000 $11 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.